4 quarters tracked · Beat rate 100% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $0.94 | $1.12 | +19.4% | Beat |
| Q4 2025 | 2025-12-31 | $1.17 | $1.28 | +9.2% | Beat |
| Q3 2025 | 2025-09-30 | $0.80 | $1.18 | +47.8% | Beat |
| Q2 2025 | 2025-06-30 | $0.77 | $0.86 | +11.6% | Beat |
Earnings Beat Rate
Globus Medical has beaten analyst EPS estimates in 4 of 4 tracked quarters (100% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →